Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-25-055495)

Filing Details

Accession Number:: 0001104659-25-055495
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-06-02 16:42:07
Reporting Period:: 2025-05-30

Filing Date:: 2025-06-02
Accepted Time:: 2025-06-02 16:42:07
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1390478	Sellas Life Sciences Group Inc.	SLS	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1352455	Jane Wasman	C/O Sellas Life Sciences Group, Inc., 7 Times Square, Suite 2503 New York NY 10036		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2025-05-30	20,000	$1.69	30,400	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The shares were purchased in multiple transactions at a price of $1.69. The reporting person undertakes to provide SELLAS Life Sciences Group, Inc., any security holder of SELLAS Life Sciences Group, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at the price set forth in this footnote.